Evaluation of software-based telephone Counseling to enhance medication persistency among patients with multiple sclerosis

被引:42
作者
Berger, Bruce A. [1 ]
Liang, Huigang [2 ]
Hudmon, Karen Suchanek [3 ]
机构
[1] Auburn Univ, Auburn, AL 36849 USA
[2] Florida Atlantic Univ, Dept Informat Technol & Operat Management, Ft Lauderdale, FL USA
[3] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
multiple sclerosis; interferon beta-1a; Avonex; Transtheoretical Model of Change; motivational interviewing; medication persistence; adherence;
D O I
10.1331/1544345054475469
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the effect of a software-supported intervention based on the Transtheoretical Model of Change and motivational interviewing on decreasing discontinuation ( or increasing persistency) of Avonex ( interferon beta-1a-Biogen), a medication for treatment of multiple sclerosis ( MS). Design: Randomized controlled experimental design comparison of software-based telephone counseling ( intervention group) and standard care ( control group). Setting: United States. Participants: 366 patients with MS. Intervention: Software-based telephone counseling. Main Outcome Measure: Discontinuation of Avonex treatment and movement among stages of the Transtheoretical Model of Change. Results: Patients in the software intervention group demonstrated a statistically significantly lower proportion of Avonex treatment (1.2%) discontinuation than the standard care group (8.7%). In addition, stage movement away from discontinuation of Avonex (i.e., toward continuation of therapy) was significantly higher in the treatment group. Conclusion: The Transtheoretical Model of Change constructs and motivational interviewing processes were effectively incorporated into a software-based intervention program, and this significantly decreased the proportion of patients who discontinued treatment of MS with Avonex. The integration of behavioral theory with information systems offers a promising approach for pharmacists and other providers to promote medication persistency.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 5 条
[1]  
[Anonymous], 1992, PROGR BEHAV MODIFICA
[2]  
Berger Bruce A, 2004, J Am Pharm Assoc (2003), V44, P445, DOI 10.1331/1544345041475607
[3]  
JOHNSON SS, 1998, J SOCIAL ADM PHARM, V15, P135
[4]  
Miller W.R., 2003, The motivational interviewing skills code (MISC) manual
[5]  
Prochaska J.O., 1984, SYSTEMS PSYCHOTHERAP, V2nd